(株)Veritas In Silico

主市場業種証券コード/EDINET英名称
東証GRT医薬品130A/ - -

日証金(2025-06-20付)

信用売り残高
0株
前日比
0%
信用買い残高
1万9800株
前日比
-2.46%

□もっと見る

東証(2025-06-13付)

信用売り残高
0株
前週比
0%
信用買い残高
29万2200株
前週比
14.45%

□もっと見る

日証協(2025-06-13付)

貸付残高
31万200株
前週比
-1.74%
貸付新規
1700株
前週比
-48.48%

□もっと見る

機関の空売り残高情報

計算日空売り者残高割合増減率残高数量増減量備考
2024/07/03Barclays Capital Securities0.630%0%41,000株
2024/05/15Integrated Core Strategies3.700%+0.120%237,600株+7,300
2024/04/01Integrated Core Strategies3.580%-0.020%230,300株-1,000
2024/03/29Integrated Core Strategies3.600%+0.050%231,300株+7,100
2024/03/11Integrated Core Strategies3.550%+0.430%224,200株+27,000
2024/03/05Integrated Core Strategies3.120%+0.340%197,200株+21,900
2024/03/01Integrated Core Strategies2.780%+0.460%175,300株+28,800
2024/02/27Integrated Core Strategies2.320%+0.490%146,500株+30,700
2024/02/26Integrated Core Strategies1.830%+0.170%115,800株+10,800
2024/02/22Integrated Core Strategies1.660%+0.470%105,000株+30,000
2024/02/20Integrated Core Strategies1.190%+0.400%75,000株+25,000
2024/02/15Integrated Core Strategies0.790%0%50,000株

Page Top